BIOTECHNOLOGY

ACIP Recommends Use of Merck’s ENFLONSIA for Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season

ENFLONSIA is the first and only RSV preventive option for [...]

By |2025-06-26T17:48:09+00:00June 26, 2025|3rd Party Medical Device Industry News|Comments Off on ACIP Recommends Use of Merck’s ENFLONSIA for Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season

Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation

“MERCURIUS Total DRUG-seq represents a new frontier in transcriptome-scale compound [...]

By |2025-06-19T15:15:59+00:00June 19, 2025|3rd Party Medical Device Industry News|Comments Off on Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation
Go to Top